Source: International Congress 2019 – Long-term evaluation and control of airway diseases
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
J. Bordas-Martinez (Barcelona, Spain), Y. Pascual González (Barcelona, Spain), S. Aso González (Barcelona, Spain), N. Jose Bazán (Barcelona, Spain), A. Romero Ortiz (Barcelona, Spain), J. Dorca Sargatal (Barcelona, Spain), S. Santos Pérez (Barcelona, Spain), M. Muñoz-Esquerre (Barcelona, Spain). Impact of fine particle concentration in asthma control. 2607

Member's Comments

No comment yet.

Related content which might interest you: In vitro fine particle dose of drug formulation used in asthma & COPD Source: Virtual Congress 2020 – Asthma inhalers: devices and adherence studies Year: 2020 Single-breath, real time measurement of lung deposition of tobacco smoke fine particles: the correlation between particle burden and regional particle deposition fraction Source: Annual Congress 2007 - The versatile aspects of nicotine addiction Year: 2007 Effect of dust aerosol in patients with asthma Source: Annual Congress 2011 - Diagnosis and treatment of inflammatory respiratory diseases Year: 2011 Dose-response effect of small particle vs standard size particle inhaled corticosteroids on severe asthma exacerbations by sex Source: International Congress 2015 – Management of asthma and other respiratory diseases in primary care Year: 2015 In vitro fine particle characteristics of budesonide containing MDI and DPI products Source: Eur Respir J 2002; 20: Suppl. 38, 541s Year: 2002 Effect of inhaled corticosteroids depends on its particle size Source: Annual Congress 2009 - Models of chronic airways disease and therapy Year: 2009 The impact of a high fine particle fraction inhaled long acting ß2 agonist (Formoterol) on airway function in asthma: evaluation with oxygen enhanced MRI and multiple breath washout. Source: International Congress 2017 – Imaging markers for COPD and asthma Year: 2017 Effect of particle size of dry powder mannitol on lung deposition in healthy subjects Source: Eur Respir J 2006; 28: Suppl. 50, 434s Year: 2006 Optimization of inhalation treatment – Evaluation of influence of spacer integrated with the spirometer on aerosol particle distribution from pMDI-EB Source: Annual Congress 2010 - Drug delivery and pharmacokinetics I Year: 2010 Impact of PAHs exposure on exacerbation frequency in asthma using a new grid-scale simulation of PM2.5-PAHs distribution Source: Virtual Congress 2020 – Air pollution and comorbidities Year: 2020 Increased asthma medication use in association with ambient fine and ultrafine particles Source: Eur Respir J 2002; 20: 691-702 Year: 2002 Optimization of inhalation treatment – Assessment of the influence of diluent and air humidity on particle distribution of colistin administered by BCTS method [bronchial control treatment system] Source: Annual Congress 2010 - Drug delivery and pharmacokinetics I Year: 2010 Stability and achievement of asthma control with higher doses of inhaled conticosteroids regular treatment Source: Annual Congress 2011 - Asthma management and response Year: 2011 Assessing the relative contribution of the asthma control testÔ (ACT) and spirometry in predicting asthma control Source: Eur Respir J 2004; 24: Suppl. 48, 472s Year: 2004 Median mass aerodynamic diameter (MMAD) and fine particle fraction (FPF): Influence on lung deposition? Source: International Congress 2014 – Asthma and COPD devices and treatments Year: 2014 Small airway function in asthma patients treated with an ultrafine inhaled steroid aerosol Source: Eur Respir J 2004; 24: Suppl. 48, 581s Year: 2004 Effect of nanoparticles on the respiratory epithelium in vitro: role of chemical composition and particle size Source: Eur Respir J 2007; 30: Suppl. 51, 476s Year: 2007 Change from MDI to DPI in asthma: effects on climate emissions and disease control Source: Virtual Congress 2021 – Asthma inhalers: new devices and adherence Year: 2021 Numerical simulation of the effect of inhalation parameters and disease severity on the deposition of dry powder aerosol drugs in COPD patients Source: Virtual Congress 2020 – Inhaler devices in COPD: technical advances, adherence studies and more Year: 2020